Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Sela

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
International Immunology|May 24, 2011
Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodiesEsther J Witsch, Georg Mahlknecht, Jean Wakim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitisRina Aharoni, Avia Herschkovitz, Raya Eilam, et al.
Scientific Reports|March 13, 2019
Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetateRina Aharoni, Nofar Schottlender, Dekel D Bar-Lev, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studiesDvora Teitelbaum, Rina Aharoni, Ety Klinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapyLilach M Friedman, Ariel Rinon, Bilha Schechter, et al.
Journal of Neuroimmunology|November 13, 2016
Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosisRina Aharoni, Chava Rosen, Elias Shezen, et al.
Journal of Neuroimmunology|June 14, 2020
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosisRina Aharoni, Raya Eilam, Nofar Schottlender, et al.
Biochemical and Biophysical Research Communications|April 7, 2019
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodiesRuth Maron, Bilha Schechter, Nishanth Belugali Nataraj, et al.
Glia|February 1, 2014
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetateRenana From, Raya Eilam, Dekel D Bar-Lev, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2013
Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFRDaniela A Ferraro, Nadège Gaborit, Ruth Maron, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
International Immunology|May 24, 2011
Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodiesEsther J Witsch, Georg Mahlknecht, Jean Wakim, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 2008
Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitisRina Aharoni, Avia Herschkovitz, Raya Eilam, et al.
Scientific Reports|March 13, 2019
Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetateRina Aharoni, Nofar Schottlender, Dekel D Bar-Lev, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studiesDvora Teitelbaum, Rina Aharoni, Ety Klinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2005
Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapyLilach M Friedman, Ariel Rinon, Bilha Schechter, et al.
Journal of Neuroimmunology|November 13, 2016
Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosisRina Aharoni, Chava Rosen, Elias Shezen, et al.
Journal of Neuroimmunology|June 14, 2020
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosisRina Aharoni, Raya Eilam, Nofar Schottlender, et al.
Biochemical and Biophysical Research Communications|April 7, 2019
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodiesRuth Maron, Bilha Schechter, Nishanth Belugali Nataraj, et al.
Glia|February 1, 2014
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetateRenana From, Raya Eilam, Dekel D Bar-Lev, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 16, 2013
Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFRDaniela A Ferraro, Nadège Gaborit, Ruth Maron, et al.
Pageof 5